Two of our speakers, IBM’s Prasad Kodali (left) and Weill Cornell Medical College’s Lewis Cantley, chat before the festivities get underway.
Not an empty seat in the house. The crowd has continued to grow for our New York biotech events, a testament to the momentum building in the city.
To give you a sense of the growth in New York biotech, behind these attendees is the Alexandria Center’s latest tower, mid-construction. It didn’t exist a few years ago.
Speaking of the Alexandria Center, here’s Alexandria Real Estate Equities CEO Joel Marcus giving an overview of the city’s life science efforts. The spot we were all sitting in was a “contaminated laundry site” not too long ago, he said.
Seattle’s Accelerator Corp. has started up two companies, Petra Pharma and Lodo Therapeutics, since opening up a branch in New York. David Schubert, Accelerator’s chief operating officer, gives a behind-the-scenes look at how those two companies came together with the help of scientific founders Lewis Cantley (left, Petra) and Sean Brady (right, Lodo).
Flagship Ventures partner Doug Cole told the audience what led his firm to help manage a $150 million biotech fund for New York City---and what locals must do to maximize the “raw potential” in New York’s biotech scene.
Among the attendees looking on is Jason Park (front right), a principal at Flagship and the point man for the firm’s biotech efforts in New York.
We always try to give folks a chance to chime in and ask questions.
Columbia University professor and Kallyope co-founder Charles Zuker talks about how the circuitry of the gut-brain axis---an information superhighway between the cells in our guts and brain---is implicated in our senses of what tastes sweet or bitter.
With much of the crowd making their way out to go schmooze, Kallyope CEO and ex-Merck executive Nancy Thornberry sticks around to talk to an attendee.
The post-event networking was a zoo. Attendees stayed late to keep the party going.
One of the locals to show up was Organovo and Modern Meadow co-founder Andras Forgacs. Modern Meadow is based in the Brooklyn Army Terminal’s “BioBAT” space.
The vibe at the event was great. You do get the sense that this is a group passionate about changing things in New York.
Exchanging contacts? Checking their March Madness brackets? It must be one of the two.
Last week, we held our yearly Big Apple biotech event, “New York’s Life Science Disruptors,” which provides an inside look at the people and companies that are shaping the emerging life sciences scene in the city. As per usual, today I’m circling back with the photos.
Just wanted to say thanks again to all the folks who came out, as well as to our speakers, sponsors, and event host Alexandria Real Estate Equities. (And a hat tip to Keith Spiro of Keith Spiro Photography for the photos.) Hope to see you all again next year.
Ben Fidler is Xconomy's Deputy Editor, Biotechnology. You can e-mail him at firstname.lastname@example.org Follow @benthefidler
© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.